4.82
price up icon1.26%   0.06
after-market Handel nachbörslich: 4.82
loading

Redhill Biopharma Ltd Adr Aktie (RDHL) Neueste Nachrichten

pulisher
Feb 21, 2025

Redhill Biopharma stock hits 52-week low at $4.79 - Investing.com

Feb 21, 2025
pulisher
Feb 07, 2025

Earnings call transcript: RedHill Biopharma Q1 2022 sees revenue dip - Investing.com

Feb 07, 2025
pulisher
Feb 05, 2025

RedHill tests opaganib with Bayer's drug in prostate cancer study By Investing.com - Investing.com South Africa

Feb 05, 2025
pulisher
Feb 04, 2025

RedHill tests opaganib with Bayer's drug in prostate cancer study - Investing.com India

Feb 04, 2025
pulisher
Jan 21, 2025

RedHill stock rises on expanded Medicare coverage - Investing.com

Jan 21, 2025
pulisher
Jan 21, 2025

RedHill stock rises on expanded Medicare coverage By Investing.com - Investing.com South Africa

Jan 21, 2025
pulisher
Jan 15, 2025

GAMMA Investing LLC Buys 595 Shares of ArcelorMittal S.A. (NYSE:MT) - Defense World

Jan 15, 2025
pulisher
Dec 02, 2024

RedHill wins $8 million judgment in New York court - Investing.com India

Dec 02, 2024
pulisher
Nov 30, 2024

RedHill Biopharma: FDA Accepts TALICIA’s NDA - Investing.com

Nov 30, 2024
pulisher
Oct 27, 2024

COVID-19 Competitive Landscape 2024 (Updated) - openPR

Oct 27, 2024
pulisher
Oct 14, 2024

BARDA funds RedHill's opaganib for Ebola treatment - Investing.com

Oct 14, 2024
pulisher
Oct 01, 2024

Medi-Cal extends Talicia access for 15 million Californians - Investing.com

Oct 01, 2024
pulisher
Sep 09, 2024

RedHill's Talicia® Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines - StockTitan

Sep 09, 2024
pulisher
Aug 27, 2024

Can Redhill Biopharma Ltd. ADR Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle

Aug 27, 2024
pulisher
Aug 26, 2024

RDHL stock’s current quarter earnings estimates: What analysts predict? - US Post News

Aug 26, 2024
pulisher
Aug 21, 2024

Talicia® Launched in the United Arab Emirates - Yahoo Finance

Aug 21, 2024
pulisher
Aug 20, 2024

Redhill Biopharma stock hits 52-week high of $8.03 amid volatility - Investing.com

Aug 20, 2024
pulisher
Aug 19, 2024

Opaganib shows promise in obesity, diabetes treatment - Investing.com

Aug 19, 2024
pulisher
Aug 19, 2024

RedHill Biopharma Announces Positive Obesity and Diabetes Results with Opaganib - Investing.com

Aug 19, 2024
pulisher
Aug 16, 2024

Teva Pharmaceutical Industries Limited (TEVA) Stock Price, News, Quote & History - Yahoo Finance

Aug 16, 2024
pulisher
Aug 16, 2024

RedHill Biopharma Announces Plan to Implement ADS Ratio Change - PR Newswire

Aug 16, 2024
pulisher
Jul 22, 2024

RedHill Biopharma finalizes agreement to enhance cash position - Investing.com

Jul 22, 2024
pulisher
Mar 11, 2024

RedHill secures new US patent for H. pylori treatment Talicia - Investing.com

Mar 11, 2024
pulisher
Jan 11, 2024

Balancing Acidity: Exploring the Proton Pump Inhibitors Market - openPR

Jan 11, 2024
pulisher
Nov 29, 2023

symbol__ Stock Quote Price and Forecast - CNN

Nov 29, 2023
pulisher
Nov 27, 2023

RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034 - PR Newswire

Nov 27, 2023
pulisher
Jul 06, 2023

Phil and RedHill Biopharma Partner to Increase Access to Talicia® - Business Wire

Jul 06, 2023
pulisher
Apr 19, 2023

Peptic Ulcer Drugs Market Drivers Analysis | CAGR of 3.5% - Market.us

Apr 19, 2023
pulisher
Apr 17, 2023

Benign Growth For RedHill Biopharma Ltd. (NASDAQ:RDHL) Underpins Stock's 41% Plummet - Yahoo Finance

Apr 17, 2023
pulisher
Dec 05, 2022

RedHill’s Aemcolo® Granted FDA QIDP 5-Year Exclusivity Extension - BioSpace

Dec 05, 2022
pulisher
Oct 26, 2022

RedHill presents New Talicia® and Movantik® data analyses at ACG 2022 - EurekAlert

Oct 26, 2022
pulisher
Jun 21, 2022

Cathie Wood Predictions 2022 - New Trader U

Jun 21, 2022
pulisher
May 25, 2022

RedHill presents new Talicia® data analyses at DDW 2022 - EurekAlert

May 25, 2022
pulisher
Dec 30, 2021

RedHill Biopharma Stock: Looking At An Unexciting Dead-End (NASDAQ:RDHL) - Seeking Alpha

Dec 30, 2021
pulisher
Feb 18, 2021

RedHill Biopharma Strengthens Partnership with Cosmo Pharmaceuticals with Manufacturing Agreements for Movantik and RHB-204 - BioSpace

Feb 18, 2021
pulisher
Jan 11, 2021

RedHill's Partner Cosmo Pharmaceuticals Successfully Completes Phase 2 Study of Rifamycin SV-MMX 600mg in IBS-D - PR Newswire

Jan 11, 2021
pulisher
Sep 23, 2020

RedHill Gets Nod in Brazil for Coronavirus Study on Opaganib - Yahoo Finance

Sep 23, 2020
pulisher
Apr 02, 2020

AstraZeneca divestment of Movantik to RedHill Biopharma completed - AstraZeneca

Apr 02, 2020
pulisher
Feb 25, 2020

The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement - Yahoo Finance

Feb 25, 2020
pulisher
Jan 21, 2020

RedHill Biopharma to Focus Commercial Efforts on Talicia® - GlobeNewswire

Jan 21, 2020
pulisher
Dec 16, 2019

Is Senseonics Holdings, Inc. (SENS) Going to Burn These Hedge Funds? - Yahoo Finance

Dec 16, 2019
pulisher
May 28, 2019

RedHill Biopharma: TALICIA Launch For H. Pylori In Sight - Investing.com

May 28, 2019
pulisher
Sep 04, 2018

RedHill Biopharma's Drug Pipeline May Merit Substantial Upside, And Potential Catalysts Are On The Horizon - Seeking Alpha

Sep 04, 2018
pulisher
Apr 05, 2017

RedHill Biopharma Announces Exclusive U.S. License from Entera Health for Commercial GI Product EnteraGam® - NAI 500

Apr 05, 2017
pulisher
Jul 15, 2015

RedHill Biopharma files for further Nasdaq offering - גלובס

Jul 15, 2015
pulisher
Jun 16, 2015

RedHill Biopharma (RDHL) Stock Price, News & Analysis - MarketBeat

Jun 16, 2015
$78.95
price up icon 0.92%
$11.11
price up icon 0.82%
$35.52
price up icon 0.57%
$119.11
price down icon 1.31%
$11.39
price up icon 1.24%
$128.57
price down icon 0.02%
Kapitalisierung:     |  Volumen (24h):